HEAR FROM PEERS

Peer-to-peer learning hub

Play Video

Improving Interstitial Lung Disease Diagnosis in a Multidisciplinary Discussion (MDD) Team Incorporating a Genomic Classifier

Listen to ILD experts provide an overview of their MDD and how the Envisia Genomic Classifier can be integrated into the ILD diagnostic algorithm. This ATS industry innovations webinar recording also includes a review and discussion of 3 real world cases in which the genomic classifier test impacted decision making.

Play Video

72 year old active male with exertional dyspnea

Hear ILD pulmonologist experts discuss the diagnostic workup for this patient including how the Envisia Genomic Classifier impacted clinical decision making.

Play Video

80 year old male with progressive shortness of breath

Hear ILD pulmonologist experts discuss the diagnostic workup for this patient including how the Envisia Genomic Classifier impacted clinical decision making.

Play Video

61 year old female with worsening lung function

Hear ILD pulmonologist experts discuss the diagnostic workup for this patient including how the Envisia Genomic Classifier impacted clinical decision making.

Case Studies & Presentations

Envisia resource library

Watch case studies and testimonials from physicians or on-demand videos about Envisia and its clinical utility.

Envisia_HearfromPeers_Thumbnail_Presentation_Jan18
Envisia_Video-Play-Button

Improving ILD Diagnosis and Predicting Clinical Progression with the Envisia Genomic Classifier

Speakers discuss updated IPF/PPF guidelines, key utility data, and the role of the Envisia Genomic Classifier in the diagnosis and prognosis of ILD. New data is presented that demonstrates how the Envisia Classifier can predict clinical progression in fibrotic ILD.
Envisia_HearfromPeers_Thumbnail_Presentation_May15-2022
Envisia_Video-Play-Button

Integrating the Envisia Genomic Classifier to Improve ILD Diagnostic & Prognostic Confidence

Speakers review the recently updated IPF/PPF Clinical Diagnosis Guideline and how they incorporate the Envisia Genomic Classifier as part of their workup for a more confident ILD diagnosis and prognosis.
Envisia_HearfromPeers_Thumbnail_Data_ATS2020
Envisia_Video-Play-Button

ATS 2020 Virtual ePoster

Dr. Hajari Case discusses how the Envisia classifier combined with HRCT identified twice as many UIP patients than radiology alone.

Detects genomic UIP pattern to improve ILD diagnostic confidence

Usual interstitial pneumonia (UIP) is a critical factor in differentiating idiopathic pulmonary fibrosis (IPF) from other interstitial lung diseases (ILDs). The Envisia classifier improves ILD diagnostic and prognostic confidence, and can identify twice as many UIP patients than radiology alone when combined with HRCT.